Gilead Sciences (GILD) Total Debt (2009 - 2026)

Gilead Sciences has reported Total Debt for 18 years, with the latest figure at $22.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Debt fell 11.13% year-over-year to $22.2 billion; the trailing twelve-month figure through Mar 2026 stood at $22.2 billion (down 11.13% YoY), and the FY2025 full-year result was $24.9 billion, down 6.65% from the prior year.
• Total Debt for Q1 2026 stood at $22.2 billion, down from $24.9 billion in the prior quarter.
• The five-year high for Total Debt was $26.7 billion in Q4 2024, with the low at $22.2 billion in Q1 2026.
• Historically, Total Debt has averaged $24.9 billion across 5 years, with a median of $25.0 billion in 2023.
• Annual changes were most pronounced in 2022 — Total Debt slipped 13.12% — and 2025, when it gained 7.28%.
• Gilead Sciences' Total Debt stood at $25.2 billion in 2022, then declined by 0.96% to $25.0 billion in 2023, then climbed by 6.9% to $26.7 billion in 2024, then dropped by 6.65% to $24.9 billion in 2025, then declined by 11.08% to $22.2 billion in 2026.
• The last three Total Debt figures came in at $22.2 billion (Q1 2026), $24.9 billion (Q4 2025), and $24.9 billion (Q3 2025), per Business Quant data.